Apo-Ipravent en es it fr

Apo-Ipravent Brand names, Apo-Ipravent Analogs

Apo-Ipravent Brand Names Mixture

  • Combivent Inhalation Aerosol (Ipratropium Bromide + Salbutamol Sulfate)
  • Combivent Inhalation Solution (Ipratropium Bromide + Salbutamol Sulfate)
  • Duovent Udv (Fenoterol Hydrobromide + Ipratropium Bromide)
  • Ratio-Ipra Sal Udv (Ipratropium Bromide + Salbutamol Sulfate)

Apo-Ipravent Chemical_Formula


Apo-Ipravent RX_link


Apo-Ipravent fda sheet

Apo-Ipravent FDA

Apo-Ipravent msds (material safety sheet)

Apo-Ipravent Synthesis Reference

K. Zeile et al.,U.S. Pat. 3,505,337 (1970)

Apo-Ipravent Molecular Weight

332.457 g/mol

Apo-Ipravent Melting Point


Apo-Ipravent H2O Solubility

Freely soluble

Apo-Ipravent State


Apo-Ipravent LogP

No information avaliable

Apo-Ipravent Dosage Forms

Aerosol (with propellants); Liquid; Metered-dose (aerosol); Metered-dose (pump); Solution

Apo-Ipravent Indication

For maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease, including chronic bronchitis and emphysema.

Apo-Ipravent Pharmacology

Ipratropium bromide, a synthetic ammonium compound structurally similar to atropine, is used as a bronchodilator in the management of cholinergic-mediated bronchospasm associated with chronic obstructive pulmonary disease and in the treatment of rhinorrhea associated with the common cold or with allergic or nonallergic seasonal rhinitis.

Apo-Ipravent Absorption

Inhalation (local)-minimal; Nasal-rapid and minimal

Apo-Ipravent side effects and Toxicity

LD50=1001mg/kg (orally in mice)

Apo-Ipravent Patient Information

Apo-Ipravent Organisms Affected

Humans and other mammals